A model of bi-mode transmission dynamics of hepatitis C with optimal control

In this paper, we present a rigorous mathematical analysis of a deterministic model for the transmission dynamics of hepatitis C. The model is suitable for populations where two frequent modes of transmission of hepatitis C virus, namely unsafe blood transfusions and intravenous drug use, are dominant. The susceptible population is divided into two distinct compartments, the intravenous drug users and individuals undergoing unsafe blood transfusions. Individuals belonging to each compartment may develop acute and then possibly chronic infections. Chronically infected individuals may be quarantined. The analysis indicates that the eradication and persistence of the disease is completely determined by the magnitude of basic reproduction number Rc. It is shown that for the basic reproduction number Rc < 1, the disease-free equilibrium is locally and globally asymptotically stable. For Rc > 1, an endemic equilibrium exists and the disease is uniformly persistent. In addition, we present the uncertainty and sensitivity analyses to investigate the influence of different important model parameters on the disease prevalence. When the infected population persists, we have designed a time-dependent optimal quarantine strategy to minimize it. The Pontryagin’s Maximum Principle is used to characterize the optimal control in terms of an optimality system which is solved numerically. Numerical results for the optimal control are compared against the constant controls and their efficiency is discussed.

[1]  Global Analysis of an SEIRS Model with Saturating Contact Rate , 2012 .

[2]  D. Kirschner,et al.  Optimal control of the chemotherapy of HIV , 1997, Journal of mathematical biology.

[3]  Herbert W. Hethcote,et al.  Stability of the endemic equilibrium in epidemic models with subpopulations , 1985 .

[4]  Xiefei Yan,et al.  Optimal quarantine and isolation strategies in epidemics control , 2007 .

[5]  J. Janssen,et al.  Deterministic and Stochastic Optimal Control , 2013 .

[6]  Folashade B. Agusto,et al.  Optimal chemoprophylaxis and treatment control strategies of a tuberculosis transmission model , 2009 .

[7]  J. Hyman,et al.  The basic reproductive number of Ebola and the effects of public health measures: the cases of Congo and Uganda. , 2004, Journal of theoretical biology.

[8]  A. K. Khuwaja.,et al.  Treatment and vaccination for hepatitis C: present and future. , 2008, Journal of Ayub Medical College, Abbottabad : JAMC.

[9]  Suxia Zhang,et al.  Dynamics and application of an epidemiological model for hepatitis C , 2012, Math. Comput. Model..

[10]  Louisa Degenhardt,et al.  Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews , 2011, The Lancet.

[11]  G. Hirschfield,et al.  Managing hepatitis C virus infection , 2009, BMJ : British Medical Journal.

[12]  Suzanne Lenhart,et al.  Optimal control of treatments in a two-strain tuberculosis model , 2002 .

[13]  Xiao-Qiang Zhao,et al.  Dynamical systems in population biology , 2003 .

[14]  R. Purcell,et al.  Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus , 1990, Hepatology.

[15]  W. Getz,et al.  Curtailing transmission of severe acute respiratory syndrome within a community and its hospital† , 2003, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[16]  L. S. Pontryagin,et al.  Mathematical Theory of Optimal Processes , 1962 .

[17]  K. Hadeler,et al.  Demography and epidemics. , 1990, Mathematical biosciences.

[18]  H. Behncke Optimal control of deterministic epidemics , 2000 .

[19]  BScN Noureen Jiwani MScN A Silent Storm : Hepatitis C in Pakistan , 2015 .

[20]  D Clancy,et al.  Optimal intervention for epidemic models with general infection and removal rate functions , 1999, Journal of mathematical biology.

[21]  M. L. Chambers The Mathematical Theory of Optimal Processes , 1965 .

[22]  Y. Waheed,et al.  Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors. , 2009, World journal of gastroenterology.

[23]  M. Li,et al.  Global dynamics of a SEIR model with varying total population size. , 1999, Mathematical Biosciences.

[24]  Edoardo Cervoni,et al.  Hepatitis C , 1998, The Lancet.

[25]  Yun Zou,et al.  Optimal and sub-optimal quarantine and isolation control in SARS epidemics , 2007, Mathematical and Computer Modelling.

[26]  R. Esteban,et al.  Epidemiology of hepatitis C virus infection. , 1993, Journal of hepatology.

[27]  J. Hoofnagle,et al.  The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. , 1991, The American journal of gastroenterology.

[28]  A. Bhalla,et al.  Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. , 1997, Gastroenterology.

[29]  Anurag Maheshwari,et al.  Management of acute hepatitis C. , 2010, Clinics in liver disease.

[30]  E. Armstrong,et al.  Burden of illness of hepatitis C from a managed care organization perspective , 2004, Current medical research and opinion.

[31]  S. Lenhart,et al.  OPTIMIZING CHEMOTHERAPY IN AN HIV MODEL , 1998 .

[32]  H. Hethcote,et al.  Effects of quarantine in six endemic models for infectious diseases. , 2002, Mathematical biosciences.

[33]  Zhongyi Xiang,et al.  Global Analysis of an Endemic Model with Acute and Chronic Stages 1 , 2012 .

[34]  Carlos Castillo-Chavez,et al.  Diseases with chronic stage in a population with varying size. , 2003, Mathematical biosciences.

[35]  M. Thod Global Burden of Disease (GBD) for Hepatitis C , 2004, Journal of clinical pharmacology.

[36]  Hassan Fathabadi,et al.  On Stability Analysis of Nonlinear Systems , 2012 .

[37]  D. Greenhalgh,et al.  A time since onset of injection model for hepatitis C spread amongst injecting drug users , 2013, Journal of mathematical biology.

[38]  Hem Raj Joshi,et al.  Optimal control of an HIV immunology model , 2002 .

[39]  G. Molenberghs,et al.  Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users , 2006, Journal of viral hepatitis.

[40]  D. Bentil,et al.  Mathematical modeling of Hepatitis C Virus transmission among injecting drug users and the impact of vaccination , 2010 .

[41]  H. Wedemeyer,et al.  Progress in the development of preventive and therapeutic vaccines for hepatitis C virus. , 2011, Journal of hepatology.

[42]  Xiefei Yan,et al.  CONTROL OF EPIDEMICS BY QUARANTINE AND ISOLATION STRATEGIES IN HIGHLY MOBILE POPULATIONS , 2009 .

[43]  J. Watmough,et al.  Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. , 2002, Mathematical biosciences.

[44]  S. Vermund,et al.  Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[45]  Lourdes Esteva,et al.  A model for dengue disease with variable human population , 1999, Journal of mathematical biology.

[46]  Herbert W. Hethcote,et al.  The Mathematics of Infectious Diseases , 2000, SIAM Rev..

[47]  K. Hadeler,et al.  A core group model for disease transmission. , 1995, Mathematical biosciences.

[48]  Shigui Ruan,et al.  Uniform persistence and flows near a closed positively invariant set , 1994 .